Early research (Phase 1)Study completedNCT01231919
What this trial is testing
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45